期刊文献+

癌症相关急性肺血栓栓塞症序贯抗凝治疗的研究 被引量:8

Unfavorable prognosis of cancer-associated acute pulmonary thromboembolism with sequential anticoagulation
原文传递
导出
摘要 目的探讨序贯抗凝治疗对癌症相关急性肺血栓栓塞症的预后的影响。方法对比研究2003年3月至2013年3月就诊于中国医科大学呼吸疾病研究所并接受序贯抗凝治疗的癌症相关急性肺血栓栓塞症53例和非癌症相关急性肺血栓栓塞症168例患者的临床特征和60 d随访结果。结果癌症组患者中肺癌比例最高(24.5%),其次为结肠癌(20.8%)。两组患者在年龄、性别、体重、吸烟者比例、基础疾病和严重程度等方面差异均无统计学意义。癌症相关急性肺血栓栓塞症患者序贯抗凝治疗60 d后仍有较严重的低氧血症(P=0.006),再栓塞率和病死率均显著高于非癌症组(分别为20.8%对4.2%,26.4%对5.4%,均P<0.001)。血小板减少和出血的发生率也高于非癌症组(分别为22.6%对13.7%,24.5%对8.9%,P=0.119和0.003),两组出血发生率差异有统计学意义。结论以华法林为主的序贯抗凝治疗在癌症相关急性肺血栓栓塞症患者中治疗反应差,不良反应发生较多,病死率高,预后不佳。这类患者可能需要新的抗凝方案如低分子肝素长程抗凝治疗。 Objective To analyze the treatment response of patients with cancer associated acute pulmonary thromboembo- lism to sequential anticoagulation. Methods Compare the clinical data and 60 - day follow - up information between 53 patients of acute pulmonary thromboembolism with cancer and 168 patients of acute puhnonary thromboembolism without cancer who were all treated with sequential anticoagulation in the institute of respiratory disease of China medical university from March 2003 to March 2013. Results Pulmonary cancer was most common in the patients with cancer, and colon cancer ranked the second. There was no difference between two groups in terms of age, gender, weight, smoking status, un- derlying diseases and severity. Patients of acute pulmonary thromboembolism with cancer still had more severe hypoxemia af- ter 60-day sequential anticoagulation( P = 0.006 ) , higher rate of recurrent embolism and mortality than control ( 20.8% vs 4. 2% ,P 〈0. 001 ;26.4% vs 5.4% ,P 〈0. 001 ). Thrombocytopenia and bleeding were more common in patients with caner than without (22. 6% vs 13.7 % , P = 0. 119 ;24.5 % vs 8.9 % , P = 0.003 ). Conclusion Patients of cancer-associated pul- monary thromboembolism responded badly to warfarin-based sequential antieoagulation with more adverse effects, higher mortality and worse prognosis. New protocol of anticoagulation, especially extended-period low molecular heparin might be needed for this subset of patients.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第2期183-186,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(81270146)
关键词 急性肺血栓栓塞症 癌症 抗凝 acute pulmonary thromboembolism cancer anticoagulation
  • 相关文献

参考文献7

二级参考文献101

  • 1孙葵葵,王辰,古力夏提,罗琴.深静脉血栓形成的危险因素及临床分析[J].中华结核和呼吸杂志,2004,27(11):727-730. 被引量:82
  • 2荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 3邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 4国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:79
  • 5Tapson VF. Acute pulmonary embolism [J]. N Engl J Med, 2008, 358(10): 1037-52.
  • 6Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2008, 29(18):2276-315.
  • 7Ota M, Nakamura M, Yamada N, et al. Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure[J]. Heart Vessels, 2002, 17(1): 7-11.
  • 8Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimerEJ]. Thromb Haemost, 2000, 83(3): 416-20.
  • 9Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised geneva score[J]. Ann Intern Med, 2006, 144(3): 165-71.
  • 10Zubairi AB, Husain S J, Irfan M, et al. Chest radiographs in acute pulmonary embolism [J]. J Ayub Med Coil Abbottabad, 2007, 19 (1):29-31.

共引文献2230

同被引文献78

  • 1郑红,连建华,贺颖,齐华,曾青成,Christopher Butt,董子明.中国人群凝血酶原FⅡG20210A和FVLeiden的分布[J].郑州大学学报(医学版),2006,41(1):102-104. 被引量:14
  • 2翟振国,王辰,庞宝森,杨媛华,刘艳梅,毛燕玲,刘敬忠,翁心植.凝血酶原G20210基因多态性与中国汉族人群肺血栓栓塞症的相关性[J].首都医科大学学报,2006,27(1):1-4. 被引量:7
  • 3郑策,梅丹.影响华法林抗凝血作用的有关因素[J].药物不良反应杂志,2007,9(4):256-261. 被引量:102
  • 4侯明,刘新光.恶性肿瘤相关的血栓栓塞研究进展[J].中国实用内科杂志,2007,27(20):1594-1596. 被引量:22
  • 5Tutan O,ündar B,Günay T,et al.Investigation of inherited thrombophilias in patients with pulmonary embolism[J].Blood Coagulat Fibrin,2013,24(2):140-149.
  • 6Tang YY,Sampson B,Pack S,et al.Ethnic differences in Out-of-Hospital fatal pulmonary embolism[J].Circulation,2011,123(20):2219-2225.
  • 7Kupeli E,Verdi H,Simsek A,et al.Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis[J].Thromb Hemost,2011,17(6):87-94.
  • 8Gohil R,Peck G,Sharma P,et al.The genetics of venous thromboembolism.A meta-analysis involving approximately120 000cases and 180 000controls[J].Thromb Haemost,2009,102(2):360-370.
  • 9Ro A,Hara M,Takada A,et al.The facorⅤLeiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism[J].Thromb Haemost,1999,82(6):1769-1769.
  • 10Obeidat NM,Awidi A,Sulaiman NA,et al.Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan[J].Saudi Med J,2009,30(7):921-925.

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部